Celine Martin, Johnson & Johnson group chair, cardiovascular & specialty solutions (CSS) group, oversees high-growth areas at the company’s global MedTech business. Her leadership covers Acclarent, Biosense Webster, Cerenovus and Mentor. Together, those companies bring in more than $5 billion in annual sales with more than 14,000 employees. Over 25 years at Johnson & Johnson, […]
DeviceTalks Q&A
How technology is changing the operating room
With all the hype around the use of data, artificial intelligence (AI) and other technologies, the operating room environment is ever-changing. But, how does it translate to what clinicians do in practice, and how will it improve? On the “How technology is changing the OR” panel at DeviceTalks Boston, Proximie CEO Nadine Hachach-Haram posited that […]
Zimmer Biomet’s plan to be the ‘boldest’ company in medtech
Ivan Tornos wants to transform Zimmer Biomet (NYSE: ZBH) into a fast-moving firm that better leverages tech in orthopedics. DeviceTalks Editorial Director Tom Salemi spoke with Tornos, chief operating officer of Zimmer Biomet, about the company’s broad technology offerings including its ZBEdge, Persona IQ smart knee implant and other digital data collectors. Tornos joined the […]
Forecasting the future of urology with Boston Scientific’s Meghan Scanlon
Meghan Scanlon, Boston Scientific’s president of urology and pelvic health, discusses the field and the challenges and opportunities ahead. The urology specialty faces a critical moment, with 10 urologists ready to retire for every new urologist entering the field, said Meghan Scanlon, SVP and president of urology and pelvic health at Boston Scientific (NYSE:BSX) That […]
Everything you need to know about medical device creation
Medtech development is hard. Medical device creation can require manufacturing know-how in areas as wide-ranging as electrical components, high-performance polymers, molding and machining — and that doesn’t even include the required expertise in design, regulatory requirements and achieving reimbursement. The good news is that there is now a whole ecosystem of specialized experts serving the […]
DeviceTalks Q&A: Talking targeted pain management with CEO Maria Bennett
At DeviceTalks Minnesota 2019, SPR Therapeutics founder, president & CEO Maria Bennett spoke with DeviceTalks program manager Sarah Faulkner about the company’s FDA-cleared peripheral nerve stimulation system for pain management. Want to see these interviews live? Join us at DeviceTalks West – Dec. 9-10 in Santa Clara, Calif. Sarah: Could you tell us a little […]
How Medtronic could help change healthcare for the better
Medtronic officials want the world’s largest medtech company to do more than just make medical devices: They want to help manage chronic diseases. Here are thoughts from the VP helping to lead the shift. Medtronic executive Sheri Dodd had a cousin — one of only four — die from Type 2 diabetes complications at the age […]
After 20 years at Boston Scientific, here’s what this medtech R&D leader has learned
David Knapp, VP of corporate research at Boston Scientific, has spent 20 years developing devices that cut across divisions at the medtech giant. At DeviceTalks Minnesota 2019, he gave attendees an insider’s view of what he’s learned about device development and healthcare. Want to see these interviews live? Join us at DeviceTalks West – Dec. […]
DeviceTalks Minnesota 2019: Exhibitor insights you need to know
There were a host of medtech insights to be gained on the exhibitor floor of DeviceTalks Minnesota in September, from LVAD innovations at Abbott to cybersecurity tips from Green Hills Software to Xometry’s use of AI to help device makers secure better 3D printing and other manufacturing processes. Check out what editor Chris Newmarker discovered […]
Here’s the view from the top at Hologic
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business. At DeviceTalks Boston 2018, MacMillan provided exclusive insights into the Massachusetts-based company and its evolving definition of women’s healthcare.
The future of Abbott’s electrophysiology business
At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Pederson tracked his career from a formative stint at HP to his current role as SVP of cardiac arrhythmias and heart failure at Abbott (NYSE:ABT). Check out his keynote address with DeviceTalks […]